Johnson & Johnson

Health care giant Johnson & Johnson says it's under investigation by federal prosecutors over the company's practices in marketing a line of hip replacements recalled two years ago because many failed and had to be replaced within five years.

Read More|Comment

Health care company Johnson & Johnson has been told to pay a Massachusetts teenager and her parents $63 million after she suffered a life-threatening drug reaction and lost most of her skin when she took a children's pain reliever nearly a decade ago.

Read More|Comment

Federal regulators say approval of the first generic version of cancer drug Doxil will help resolve a lingering shortage triggered by manufacturing deficiencies.

Read More|Comment

A panel of federal health experts has ruled that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies.

Read More|Comment

Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.

Read More|Comment

Pfizer Inc. and Johnson & Johnson say they are ending development of a once-promising drug designed to trea Alzheimer's disease after the treatment failed in two late-stage clinical trials.

Read More|Comment

A published report says Johnson & Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal.

Read More|Comment

Lawyers for Johnson & Johnson shareholders suing management for not fixing serious problems for years-- from shoddy manufacturing to paying kickbacks to boost sales -- have reached a tentative settlement with the health care giant.

Read More|Comment

Johnson & Johnson is seeking U.S. approval for the first new type of medicine to fight deadly tuberculosis in more than four decades.

Read More|Comment

Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto for a new use to prevent life-threatening blood clots in high-risk patients.

Read More|Comment